0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharma Sterile Fill-Finish Contract Manufacturing Market Research Report 2026
Published Date: 2026-03-27
|
Report Code: QYRE-Auto-20G17374
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharma Sterile Fill Finish Contract Manufacturing Market Research Report 2024
BUY CHAPTERS

Global Pharma Sterile Fill-Finish Contract Manufacturing Market Research Report 2026

Code: QYRE-Auto-20G17374
Report
2026-03-27
Pages:152
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharma Sterile Fill-Finish Contract Manufacturing Market

The global Pharma Sterile Fill-Finish Contract Manufacturing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
In pharmaceutical manufacturing, fill-finish operations are critical, since fill-finish is the last step before a product is packaged and ultimately delivered to the patient. By the time a drug reaches this stage, the drug product is highly valuable, as it has already been through labour- and cost-intensive production stages, including upstream processing, cell culture or fermentation and downstream purification. Failures in the integrity of the fill-finish stage can introduce microbial contamination and generate issues with formulation and dosing
The North American market for Pharma Sterile Fill-Finish Contract Manufacturing is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Pharma Sterile Fill-Finish Contract Manufacturing is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Pharma Sterile Fill-Finish Contract Manufacturing in Vaccines is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Pharma Sterile Fill-Finish Contract Manufacturing include Baxter BioPharma Solutions, Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, Pfizer CentreOne, Aenova, WuXi Biologics, Jubilant HollisterStier, Bushu Pharmaceuticals, LSNE Contract Manufacturing, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Pharma Sterile Fill-Finish Contract Manufacturing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharma Sterile Fill-Finish Contract Manufacturing. The Pharma Sterile Fill-Finish Contract Manufacturing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharma Sterile Fill-Finish Contract Manufacturing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharma Sterile Fill-Finish Contract Manufacturing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Pharma Sterile Fill-Finish Contract Manufacturing Market Report

Report Metric Details
Report Name Pharma Sterile Fill-Finish Contract Manufacturing Market
Segment by Type
  • Vials
  • Prefilled Syringes
  • Cartridges
  • Others
Segment by Application
  • Vaccines
  • Biologics and Biosimilar
  • Generics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Baxter BioPharma Solutions, Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, Pfizer CentreOne, Aenova, WuXi Biologics, Jubilant HollisterStier, Bushu Pharmaceuticals, LSNE Contract Manufacturing, Ajinomoto Bio-Pharma Services, CMIC CMO, GRAM (Grand River Aseptic Manufacturing), TAIYO Pharma Tech Co.,Ltd., HALIX, Cognate BioServices, Afton Scientific, Novasep, Emergent BioSolutions, Seikagaku, Jiangshu YAOHAI Bio-pharmaceutical, Akron Biotech, Symbiosis Pharmaceutical Services, Techdow, Vigene Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Pharma Sterile Fill-Finish Contract Manufacturing companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Pharma Sterile Fill-Finish Contract Manufacturing Market report?

Ans: The main players in the Pharma Sterile Fill-Finish Contract Manufacturing Market are Baxter BioPharma Solutions, Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, Pfizer CentreOne, Aenova, WuXi Biologics, Jubilant HollisterStier, Bushu Pharmaceuticals, LSNE Contract Manufacturing, Ajinomoto Bio-Pharma Services, CMIC CMO, GRAM (Grand River Aseptic Manufacturing), TAIYO Pharma Tech Co.,Ltd., HALIX, Cognate BioServices, Afton Scientific, Novasep, Emergent BioSolutions, Seikagaku, Jiangshu YAOHAI Bio-pharmaceutical, Akron Biotech, Symbiosis Pharmaceutical Services, Techdow, Vigene Biosciences

What are the Application segmentation covered in the Pharma Sterile Fill-Finish Contract Manufacturing Market report?

Ans: The Applications covered in the Pharma Sterile Fill-Finish Contract Manufacturing Market report are Vaccines, Biologics and Biosimilar, Generics, Other

What are the Type segmentation covered in the Pharma Sterile Fill-Finish Contract Manufacturing Market report?

Ans: The Types covered in the Pharma Sterile Fill-Finish Contract Manufacturing Market report are Vials, Prefilled Syringes, Cartridges, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Vials
1.2.3 Prefilled Syringes
1.2.4 Cartridges
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharma Sterile Fill-Finish Contract Manufacturing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Vaccines
1.3.3 Biologics and Biosimilar
1.3.4 Generics
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharma Sterile Fill-Finish Contract Manufacturing Market Perspective (2021–2032)
2.2 Global Pharma Sterile Fill-Finish Contract Manufacturing Growth Trends by Region
2.2.1 Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pharma Sterile Fill-Finish Contract Manufacturing Historic Market Size by Region (2021–2026)
2.2.3 Pharma Sterile Fill-Finish Contract Manufacturing Forecasted Market Size by Region (2027–2032)
2.3 Pharma Sterile Fill-Finish Contract Manufacturing Market Dynamics
2.3.1 Pharma Sterile Fill-Finish Contract Manufacturing Industry Trends
2.3.2 Pharma Sterile Fill-Finish Contract Manufacturing Market Drivers
2.3.3 Pharma Sterile Fill-Finish Contract Manufacturing Market Challenges
2.3.4 Pharma Sterile Fill-Finish Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharma Sterile Fill-Finish Contract Manufacturing Players by Revenue
3.1.1 Global Top Pharma Sterile Fill-Finish Contract Manufacturing Players by Revenue (2021–2026)
3.1.2 Global Pharma Sterile Fill-Finish Contract Manufacturing Revenue Market Share by Players (2021–2026)
3.2 Global Top Pharma Sterile Fill-Finish Contract Manufacturing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pharma Sterile Fill-Finish Contract Manufacturing Revenue
3.4 Global Pharma Sterile Fill-Finish Contract Manufacturing Market Concentration Ratio
3.4.1 Global Pharma Sterile Fill-Finish Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma Sterile Fill-Finish Contract Manufacturing Revenue in 2025
3.5 Global Key Players of Pharma Sterile Fill-Finish Contract Manufacturing Head Offices and Areas Served
3.6 Global Key Players of Pharma Sterile Fill-Finish Contract Manufacturing, Products and Applications
3.7 Global Key Players of Pharma Sterile Fill-Finish Contract Manufacturing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Pharma Sterile Fill-Finish Contract Manufacturing Breakdown Data by Type
4.1 Global Pharma Sterile Fill-Finish Contract Manufacturing Historic Market Size by Type (2021–2026)
4.2 Global Pharma Sterile Fill-Finish Contract Manufacturing Forecasted Market Size by Type (2027–2032)
5 Pharma Sterile Fill-Finish Contract Manufacturing Breakdown Data by Application
5.1 Global Pharma Sterile Fill-Finish Contract Manufacturing Historic Market Size by Application (2021–2026)
5.2 Global Pharma Sterile Fill-Finish Contract Manufacturing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Pharma Sterile Fill-Finish Contract Manufacturing Market Size (2021–2032)
6.2 North America Pharma Sterile Fill-Finish Contract Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (2021–2026)
6.4 North America Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharma Sterile Fill-Finish Contract Manufacturing Market Size (2021–2032)
7.2 Europe Pharma Sterile Fill-Finish Contract Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (2021–2026)
7.4 Europe Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pharma Sterile Fill-Finish Contract Manufacturing Market Size (2021–2032)
8.2 Asia-Pacific Pharma Sterile Fill-Finish Contract Manufacturing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Region (2021–2026)
8.4 Asia-Pacific Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pharma Sterile Fill-Finish Contract Manufacturing Market Size (2021–2032)
9.2 Latin America Pharma Sterile Fill-Finish Contract Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (2021–2026)
9.4 Latin America Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharma Sterile Fill-Finish Contract Manufacturing Market Size (2021–2032)
10.2 Middle East & Africa Pharma Sterile Fill-Finish Contract Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (2021–2026)
10.4 Middle East & Africa Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter BioPharma Solutions
11.1.1 Baxter BioPharma Solutions Company Details
11.1.2 Baxter BioPharma Solutions Business Overview
11.1.3 Baxter BioPharma Solutions Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.1.4 Baxter BioPharma Solutions Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.1.5 Baxter BioPharma Solutions Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.2.4 Boehringer Ingelheim Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Vetter Pharma
11.3.1 Vetter Pharma Company Details
11.3.2 Vetter Pharma Business Overview
11.3.3 Vetter Pharma Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.3.4 Vetter Pharma Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.3.5 Vetter Pharma Recent Development
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Company Details
11.4.2 Fresenius Kabi Business Overview
11.4.3 Fresenius Kabi Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.4.4 Fresenius Kabi Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.4.5 Fresenius Kabi Recent Development
11.5 Pfizer CentreOne
11.5.1 Pfizer CentreOne Company Details
11.5.2 Pfizer CentreOne Business Overview
11.5.3 Pfizer CentreOne Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.5.4 Pfizer CentreOne Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.5.5 Pfizer CentreOne Recent Development
11.6 Aenova
11.6.1 Aenova Company Details
11.6.2 Aenova Business Overview
11.6.3 Aenova Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.6.4 Aenova Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.6.5 Aenova Recent Development
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Details
11.7.2 WuXi Biologics Business Overview
11.7.3 WuXi Biologics Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.7.4 WuXi Biologics Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.7.5 WuXi Biologics Recent Development
11.8 Jubilant HollisterStier
11.8.1 Jubilant HollisterStier Company Details
11.8.2 Jubilant HollisterStier Business Overview
11.8.3 Jubilant HollisterStier Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.8.4 Jubilant HollisterStier Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.8.5 Jubilant HollisterStier Recent Development
11.9 Bushu Pharmaceuticals
11.9.1 Bushu Pharmaceuticals Company Details
11.9.2 Bushu Pharmaceuticals Business Overview
11.9.3 Bushu Pharmaceuticals Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.9.4 Bushu Pharmaceuticals Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.9.5 Bushu Pharmaceuticals Recent Development
11.10 LSNE Contract Manufacturing
11.10.1 LSNE Contract Manufacturing Company Details
11.10.2 LSNE Contract Manufacturing Business Overview
11.10.3 LSNE Contract Manufacturing Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.10.4 LSNE Contract Manufacturing Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.10.5 LSNE Contract Manufacturing Recent Development
11.11 Ajinomoto Bio-Pharma Services
11.11.1 Ajinomoto Bio-Pharma Services Company Details
11.11.2 Ajinomoto Bio-Pharma Services Business Overview
11.11.3 Ajinomoto Bio-Pharma Services Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.11.4 Ajinomoto Bio-Pharma Services Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.11.5 Ajinomoto Bio-Pharma Services Recent Development
11.12 CMIC CMO
11.12.1 CMIC CMO Company Details
11.12.2 CMIC CMO Business Overview
11.12.3 CMIC CMO Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.12.4 CMIC CMO Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.12.5 CMIC CMO Recent Development
11.13 GRAM (Grand River Aseptic Manufacturing)
11.13.1 GRAM (Grand River Aseptic Manufacturing) Company Details
11.13.2 GRAM (Grand River Aseptic Manufacturing) Business Overview
11.13.3 GRAM (Grand River Aseptic Manufacturing) Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.13.4 GRAM (Grand River Aseptic Manufacturing) Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.13.5 GRAM (Grand River Aseptic Manufacturing) Recent Development
11.14 TAIYO Pharma Tech Co.,Ltd.
11.14.1 TAIYO Pharma Tech Co.,Ltd. Company Details
11.14.2 TAIYO Pharma Tech Co.,Ltd. Business Overview
11.14.3 TAIYO Pharma Tech Co.,Ltd. Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.14.4 TAIYO Pharma Tech Co.,Ltd. Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.14.5 TAIYO Pharma Tech Co.,Ltd. Recent Development
11.15 HALIX
11.15.1 HALIX Company Details
11.15.2 HALIX Business Overview
11.15.3 HALIX Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.15.4 HALIX Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.15.5 HALIX Recent Development
11.16 Cognate BioServices
11.16.1 Cognate BioServices Company Details
11.16.2 Cognate BioServices Business Overview
11.16.3 Cognate BioServices Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.16.4 Cognate BioServices Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.16.5 Cognate BioServices Recent Development
11.17 Afton Scientific
11.17.1 Afton Scientific Company Details
11.17.2 Afton Scientific Business Overview
11.17.3 Afton Scientific Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.17.4 Afton Scientific Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.17.5 Afton Scientific Recent Development
11.18 Novasep
11.18.1 Novasep Company Details
11.18.2 Novasep Business Overview
11.18.3 Novasep Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.18.4 Novasep Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.18.5 Novasep Recent Development
11.19 Emergent BioSolutions
11.19.1 Emergent BioSolutions Company Details
11.19.2 Emergent BioSolutions Business Overview
11.19.3 Emergent BioSolutions Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.19.4 Emergent BioSolutions Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.19.5 Emergent BioSolutions Recent Development
11.20 Seikagaku
11.20.1 Seikagaku Company Details
11.20.2 Seikagaku Business Overview
11.20.3 Seikagaku Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.20.4 Seikagaku Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.20.5 Seikagaku Recent Development
11.21 Jiangshu YAOHAI Bio-pharmaceutical
11.21.1 Jiangshu YAOHAI Bio-pharmaceutical Company Details
11.21.2 Jiangshu YAOHAI Bio-pharmaceutical Business Overview
11.21.3 Jiangshu YAOHAI Bio-pharmaceutical Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.21.4 Jiangshu YAOHAI Bio-pharmaceutical Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.21.5 Jiangshu YAOHAI Bio-pharmaceutical Recent Development
11.22 Akron Biotech
11.22.1 Akron Biotech Company Details
11.22.2 Akron Biotech Business Overview
11.22.3 Akron Biotech Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.22.4 Akron Biotech Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.22.5 Akron Biotech Recent Development
11.23 Symbiosis Pharmaceutical Services
11.23.1 Symbiosis Pharmaceutical Services Company Details
11.23.2 Symbiosis Pharmaceutical Services Business Overview
11.23.3 Symbiosis Pharmaceutical Services Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.23.4 Symbiosis Pharmaceutical Services Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.23.5 Symbiosis Pharmaceutical Services Recent Development
11.24 Techdow
11.24.1 Techdow Company Details
11.24.2 Techdow Business Overview
11.24.3 Techdow Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.24.4 Techdow Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.24.5 Techdow Recent Development
11.25 Vigene Biosciences
11.25.1 Vigene Biosciences Company Details
11.25.2 Vigene Biosciences Business Overview
11.25.3 Vigene Biosciences Pharma Sterile Fill-Finish Contract Manufacturing Introduction
11.25.4 Vigene Biosciences Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
11.25.5 Vigene Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Vials
 Table 3. Key Players of Prefilled Syringes
 Table 4. Key Players of Cartridges
 Table 5. Key Players of Others
 Table 6. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Region (2021–2026)
 Table 10. Global Pharma Sterile Fill-Finish Contract Manufacturing Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Region (2027–2032)
 Table 12. Pharma Sterile Fill-Finish Contract Manufacturing Market Trends
 Table 13. Pharma Sterile Fill-Finish Contract Manufacturing Market Drivers
 Table 14. Pharma Sterile Fill-Finish Contract Manufacturing Market Challenges
 Table 15. Pharma Sterile Fill-Finish Contract Manufacturing Market Restraints
 Table 16. Global Pharma Sterile Fill-Finish Contract Manufacturing Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Players (2021–2026)
 Table 18. Global Top Pharma Sterile Fill-Finish Contract Manufacturing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pharma Sterile Fill-Finish Contract Manufacturing Revenue, 2025
 Table 19. Ranking of Global Top Pharma Sterile Fill-Finish Contract Manufacturing Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Pharma Sterile Fill-Finish Contract Manufacturing Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Pharma Sterile Fill-Finish Contract Manufacturing, Headquarters and Area Served
 Table 22. Global Key Players of Pharma Sterile Fill-Finish Contract Manufacturing, Products and Applications
 Table 23. Global Key Players of Pharma Sterile Fill-Finish Contract Manufacturing, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Pharma Sterile Fill-Finish Contract Manufacturing Revenue Market Share by Type (2021–2026)
 Table 27. Global Pharma Sterile Fill-Finish Contract Manufacturing Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Pharma Sterile Fill-Finish Contract Manufacturing Revenue Market Share by Type (2027–2032)
 Table 29. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Pharma Sterile Fill-Finish Contract Manufacturing Revenue Market Share by Application (2021–2026)
 Table 31. Global Pharma Sterile Fill-Finish Contract Manufacturing Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Pharma Sterile Fill-Finish Contract Manufacturing Revenue Market Share by Application (2027–2032)
 Table 33. North America Pharma Sterile Fill-Finish Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Pharma Sterile Fill-Finish Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Pharma Sterile Fill-Finish Contract Manufacturing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Pharma Sterile Fill-Finish Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Pharma Sterile Fill-Finish Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Country (US$ Million), 2027–2032
 Table 48. Baxter BioPharma Solutions Company Details
 Table 49. Baxter BioPharma Solutions Business Overview
 Table 50. Baxter BioPharma Solutions Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 51. Baxter BioPharma Solutions Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 52. Baxter BioPharma Solutions Recent Development
 Table 53. Boehringer Ingelheim Company Details
 Table 54. Boehringer Ingelheim Business Overview
 Table 55. Boehringer Ingelheim Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 56. Boehringer Ingelheim Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 57. Boehringer Ingelheim Recent Development
 Table 58. Vetter Pharma Company Details
 Table 59. Vetter Pharma Business Overview
 Table 60. Vetter Pharma Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 61. Vetter Pharma Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 62. Vetter Pharma Recent Development
 Table 63. Fresenius Kabi Company Details
 Table 64. Fresenius Kabi Business Overview
 Table 65. Fresenius Kabi Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 66. Fresenius Kabi Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 67. Fresenius Kabi Recent Development
 Table 68. Pfizer CentreOne Company Details
 Table 69. Pfizer CentreOne Business Overview
 Table 70. Pfizer CentreOne Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 71. Pfizer CentreOne Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 72. Pfizer CentreOne Recent Development
 Table 73. Aenova Company Details
 Table 74. Aenova Business Overview
 Table 75. Aenova Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 76. Aenova Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 77. Aenova Recent Development
 Table 78. WuXi Biologics Company Details
 Table 79. WuXi Biologics Business Overview
 Table 80. WuXi Biologics Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 81. WuXi Biologics Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 82. WuXi Biologics Recent Development
 Table 83. Jubilant HollisterStier Company Details
 Table 84. Jubilant HollisterStier Business Overview
 Table 85. Jubilant HollisterStier Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 86. Jubilant HollisterStier Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 87. Jubilant HollisterStier Recent Development
 Table 88. Bushu Pharmaceuticals Company Details
 Table 89. Bushu Pharmaceuticals Business Overview
 Table 90. Bushu Pharmaceuticals Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 91. Bushu Pharmaceuticals Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 92. Bushu Pharmaceuticals Recent Development
 Table 93. LSNE Contract Manufacturing Company Details
 Table 94. LSNE Contract Manufacturing Business Overview
 Table 95. LSNE Contract Manufacturing Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 96. LSNE Contract Manufacturing Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 97. LSNE Contract Manufacturing Recent Development
 Table 98. Ajinomoto Bio-Pharma Services Company Details
 Table 99. Ajinomoto Bio-Pharma Services Business Overview
 Table 100. Ajinomoto Bio-Pharma Services Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 101. Ajinomoto Bio-Pharma Services Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 102. Ajinomoto Bio-Pharma Services Recent Development
 Table 103. CMIC CMO Company Details
 Table 104. CMIC CMO Business Overview
 Table 105. CMIC CMO Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 106. CMIC CMO Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 107. CMIC CMO Recent Development
 Table 108. GRAM (Grand River Aseptic Manufacturing) Company Details
 Table 109. GRAM (Grand River Aseptic Manufacturing) Business Overview
 Table 110. GRAM (Grand River Aseptic Manufacturing) Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 111. GRAM (Grand River Aseptic Manufacturing) Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 112. GRAM (Grand River Aseptic Manufacturing) Recent Development
 Table 113. TAIYO Pharma Tech Co.,Ltd. Company Details
 Table 114. TAIYO Pharma Tech Co.,Ltd. Business Overview
 Table 115. TAIYO Pharma Tech Co.,Ltd. Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 116. TAIYO Pharma Tech Co.,Ltd. Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 117. TAIYO Pharma Tech Co.,Ltd. Recent Development
 Table 118. HALIX Company Details
 Table 119. HALIX Business Overview
 Table 120. HALIX Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 121. HALIX Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 122. HALIX Recent Development
 Table 123. Cognate BioServices Company Details
 Table 124. Cognate BioServices Business Overview
 Table 125. Cognate BioServices Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 126. Cognate BioServices Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 127. Cognate BioServices Recent Development
 Table 128. Afton Scientific Company Details
 Table 129. Afton Scientific Business Overview
 Table 130. Afton Scientific Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 131. Afton Scientific Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 132. Afton Scientific Recent Development
 Table 133. Novasep Company Details
 Table 134. Novasep Business Overview
 Table 135. Novasep Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 136. Novasep Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 137. Novasep Recent Development
 Table 138. Emergent BioSolutions Company Details
 Table 139. Emergent BioSolutions Business Overview
 Table 140. Emergent BioSolutions Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 141. Emergent BioSolutions Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 142. Emergent BioSolutions Recent Development
 Table 143. Seikagaku Company Details
 Table 144. Seikagaku Business Overview
 Table 145. Seikagaku Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 146. Seikagaku Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 147. Seikagaku Recent Development
 Table 148. Jiangshu YAOHAI Bio-pharmaceutical Company Details
 Table 149. Jiangshu YAOHAI Bio-pharmaceutical Business Overview
 Table 150. Jiangshu YAOHAI Bio-pharmaceutical Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 151. Jiangshu YAOHAI Bio-pharmaceutical Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 152. Jiangshu YAOHAI Bio-pharmaceutical Recent Development
 Table 153. Akron Biotech Company Details
 Table 154. Akron Biotech Business Overview
 Table 155. Akron Biotech Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 156. Akron Biotech Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 157. Akron Biotech Recent Development
 Table 158. Symbiosis Pharmaceutical Services Company Details
 Table 159. Symbiosis Pharmaceutical Services Business Overview
 Table 160. Symbiosis Pharmaceutical Services Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 161. Symbiosis Pharmaceutical Services Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 162. Symbiosis Pharmaceutical Services Recent Development
 Table 163. Techdow Company Details
 Table 164. Techdow Business Overview
 Table 165. Techdow Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 166. Techdow Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 167. Techdow Recent Development
 Table 168. Vigene Biosciences Company Details
 Table 169. Vigene Biosciences Business Overview
 Table 170. Vigene Biosciences Pharma Sterile Fill-Finish Contract Manufacturing Product
 Table 171. Vigene Biosciences Revenue in Pharma Sterile Fill-Finish Contract Manufacturing Business (US$ Million), 2021–2026
 Table 172. Vigene Biosciences Recent Development
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Pharma Sterile Fill-Finish Contract Manufacturing Picture
 Figure 2. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Type: 2025 vs 2032
 Figure 4. Vials Features
 Figure 5. Prefilled Syringes Features
 Figure 6. Cartridges Features
 Figure 7. Others Features
 Figure 8. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Application: 2025 vs 2032
 Figure 10. Vaccines Case Studies
 Figure 11. Biologics and Biosimilar Case Studies
 Figure 12. Generics Case Studies
 Figure 13. Other Case Studies
 Figure 14. Pharma Sterile Fill-Finish Contract Manufacturing Report Years Considered
 Figure 15. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 16. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Region: 2025 vs 2032
 Figure 18. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Players in 2025
 Figure 19. Global Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Pharma Sterile Fill-Finish Contract Manufacturing Revenue in 2025
 Figure 21. North America Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. North America Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Country (2021–2032)
 Figure 23. United States Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Canada Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Country (2021–2032)
 Figure 27. Germany Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. France Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. U.K. Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Italy Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Russia Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Ireland Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Region (2021–2032)
 Figure 35. China Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Japan Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. South Korea Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Southeast Asia Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. India Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Australia & New Zealand Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Country (2021–2032)
 Figure 43. Mexico Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Brazil Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Pharma Sterile Fill-Finish Contract Manufacturing Market Share by Country (2021–2032)
 Figure 47. Israel Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Saudi Arabia Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. UAE Pharma Sterile Fill-Finish Contract Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Baxter BioPharma Solutions Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 51. Boehringer Ingelheim Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 52. Vetter Pharma Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 53. Fresenius Kabi Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 54. Pfizer CentreOne Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 55. Aenova Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 56. WuXi Biologics Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 57. Jubilant HollisterStier Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 58. Bushu Pharmaceuticals Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 59. LSNE Contract Manufacturing Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 60. Ajinomoto Bio-Pharma Services Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 61. CMIC CMO Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 62. GRAM (Grand River Aseptic Manufacturing) Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 63. TAIYO Pharma Tech Co.,Ltd. Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 64. HALIX Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 65. Cognate BioServices Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 66. Afton Scientific Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 67. Novasep Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 68. Emergent BioSolutions Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 69. Seikagaku Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 70. Jiangshu YAOHAI Bio-pharmaceutical Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 71. Akron Biotech Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 72. Symbiosis Pharmaceutical Services Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 73. Techdow Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 74. Vigene Biosciences Revenue Growth Rate in Pharma Sterile Fill-Finish Contract Manufacturing Business (2021–2026)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS